CRINVELYS

Welcome to the Brand page for “CRINVELYS”, which is offered here for Pharmaceutical preparations for the diagnosis, prevention and treatment of psychiatric, neurological, hormonal, genetic and endocrine disorders and conditions; pharmaceutical preparations for human use for diagnosis, prevention and treatment of diseases and disorders by gene therapy; pharmaceuticals for human use for the treatment of rare and orphan diseases, disorders and conditions; pharmaceutical preparations for the treatment of congenital adrenal hyperplasia;.

Its status is currently believed to be active. Its class is unavailable. “CRINVELYS” is believed to be currently owned by “Neurocrine Biosciences, Inc.”